External study 6 December 2023

The socio-economic value of adult Immunization programs (OHE)


The study “The Socio-Economic Value of Adult Immunization” by the Office of Health Economics (OHE) synthesizes existing evidence for the broad, socio-economic value of adult immunization programs.

It focuses on influenza, pneumococcal, herpes zoster (HZ), and respiratory syncytial virus (RSV) programs in 10 countries where the vaccines have been publicly recommended (Australia, Brazil, France, Germany, Italy, Japan, Poland, South Africa, Thailand, United States).  

In a forthcoming publication, to be published in April 2024, OHE will present the results of a cost-benefit analysis to quantify the socio-economic return on investment for vaccination programs in these countries.  

This study was commissioned by IFPMA.